The future for rechargeable batteries
The global medical battery market is forecast to grow at 7% per year to 2022.* Meanwhile, a number of influences are shifting the market in favour of rechargeable implantable devices. Factors include the need to reduce through-life cost, and technology improvements in the batteries themselves. This paper from EnerSys® (parent company of Quallion) looks at the market influences and why OEMs should consider rechargeable for any new implantable device design.
© 2019 EnerSys. All rights reserved.
Trademarks and logos are the property of EnerSys and its affiliates unless otherwise noted.
Much of the information on this website relates to products offered by Quallion. The materials on this website are for your general educational information only. Information you read on this website including any technical descriptions, are intended for use by persons having appropriate skill, at their own risk. Any descriptions provided are only accurate under the conditions, methods and testing approved by the manufacturer. Before using the product, buyers are advised and cautioned to make their own determination and assessment of the suitability of the product for the specific use. Buyers expressly assumes all risk and liability in connection with the use of the product for user’s intended purpose and in user’s specific application. This website contains information about products and therapies approved and cleared for use in the United States, and is intended for a United States audience. If you live outside the U.S., you may see information on this website about products or therapies that are not approved or marketed in your country.This website may contain typographical mistakes, inaccuracies, or omissions, and some information may not be complete or current. We therefore reserve the right to correct any errors, inaccuracies or omissions and to change or update information at any time without prior notice.
Quallion designs and manufactures state-of-the-art lithium-ion raw materials, cells, battery packs and new battery chemistries for medical, aerospace and defence industries. Headquartered in Sylmar, California, Quallion was founded in 1998 with a mission to develop “QUALity Lithium ION” rechargeable power sources for unique and challenging requirements. Acquired in 2013 by EnerSys®, the global leader in stored energy solutions for industrial applications, the company has continued to serve the rapidly-growing medical device market with batteries for both implantable and external devices.
Leveraging its core engineering capabilities, Quallion aims to fulfil the broadening range of customer criteria for power source design – from size constraints to biosafety and compatibility – through advanced product development. Its key innovations relate to improved safety, rechargeability, battery longevity, as well as establishing the proprietary Zero-Volt™ technology. Modelled after the FDA’s Quality System Regulations and meeting the latest ISO 13485 medical standards as well as the AS 9100D/ISO 9001 aerospace standards, Quallion’s manufacturing system is designed to achieve the high reliability required by customers.
* “Global Battery Market for Medical Devices Industry 2018-2022”, Global Information Inc, https://www.giiresearch.com/report/infi640161-global-battery-market-medical-devices-industry.html.